Bioalpha Holdings Berhad Statistics

Total Valuation

KLSE:BIOHLDG has a market cap or net worth of MYR 42.19 million. The enterprise value is 12.66 million.

Market Cap	42.19M
Enterprise Value	12.66M

Important Dates

The next estimated earnings date is Friday, May 23, 2025.

Earnings Date	May 23, 2025
Ex-Dividend Date	n/a

Share Statistics

KLSE:BIOHLDG has 1.41 billion shares outstanding. The number of shares has increased by 11.28% in one year.

Current Share Class	n/a
Shares Outstanding	1.41B
Shares Change (YoY)	+11.28%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	15.13%
Owned by Institutions (%)	20.63%
Float	866.08M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.52
PB Ratio	0.44
P/TBV Ratio	0.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.25
EV / Sales	0.16
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.23

Financial Position

The company has a current ratio of 3.73, with a Debt / Equity ratio of 0.06.

Current Ratio	3.73
Quick Ratio	2.94
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	-1.46
Interest Coverage	-97.80

Financial Efficiency

Return on equity (ROE) is -45.89% and return on invested capital (ROIC) is -26.28%.

Return on Equity (ROE)	-45.89%
Return on Assets (ROA)	-22.63%
Return on Invested Capital (ROIC)	-26.28%
Return on Capital Employed (ROCE)	-47.99%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.58
Inventory Turnover	15.63

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -64.71% in the last 52 weeks. The beta is 2.23, so KLSE:BIOHLDG's price volatility has been higher than the market average.

Beta (5Y)	2.23
52-Week Price Change	-64.71%
50-Day Moving Average	0.04
200-Day Moving Average	0.07
Relative Strength Index (RSI)	42.83
Average Volume (20 Days)	721,480

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KLSE:BIOHLDG had revenue of MYR 81.62 million and -49.94 million in losses. Loss per share was -0.04.

Revenue	81.62M
Gross Profit	-1.87M
Operating Income	-51.25M
Pretax Income	-51.87M
Net Income	-49.94M
EBITDA	-41.16M
EBIT	-51.25M
Loss Per Share	-0.04

Full Income Statement

Balance Sheet

The company has 35.33 million in cash and 5.70 million in debt, giving a net cash position of 29.63 million or 0.02 per share.

Cash & Cash Equivalents	35.33M
Total Debt	5.70M
Net Cash	29.63M
Net Cash Per Share	0.02
Equity (Book Value)	96.56M
Book Value Per Share	0.07
Working Capital	35.82M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.82 million and capital expenditures -2.10 million, giving a free cash flow of -3.92 million.

Operating Cash Flow	-1.82M
Capital Expenditures	-2.10M
Free Cash Flow	-3.92M
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is -2.29%, with operating and profit margins of -62.79% and -61.19%.

Gross Margin	-2.29%
Operating Margin	-62.79%
Pretax Margin	-63.56%
Profit Margin	-61.19%
EBITDA Margin	-50.43%
EBIT Margin	-62.79%
FCF Margin	n/a

Dividends & Yields

KLSE:BIOHLDG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.28%
Shareholder Yield	-11.28%
Earnings Yield	-118.37%
FCF Yield	-9.28%

Stock Splits

The last stock split was on December 6, 2016. It was a forward split with a ratio of 1.0117668484.

Last Split Date	Dec 6, 2016
Split Type	Forward
Split Ratio	1.0117668484

Scores

KLSE:BIOHLDG has an Altman Z-Score of 1.46. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.46
Piotroski F-Score	n/a